138 related articles for article (PubMed ID: 15147158)
1. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA Plus analyzer.
Gidenne S; Ceppa F; Fontan E; Perrier F; Burnat P
Clin Chem Lab Med; 2004 Apr; 42(4):455-61. PubMed ID: 15147158
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the albumin cobalt binding (ACB) assay for measurement of ischaemia-modified albumin (IMA) on the Beckman Coulter LX-20.
Maguire OC; O'Sullivan J; Ryan J; Cunningham SK
Ann Clin Biochem; 2006 Nov; 43(Pt 6):494-9. PubMed ID: 17132281
[TBL] [Abstract][Full Text] [Related]
3. Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome.
Immanuel S; Sanjaya AI
Acta Med Indones; 2006; 38(2):92-6. PubMed ID: 16799211
[TBL] [Abstract][Full Text] [Related]
4. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma.
Can M; Demirtas S; Polat O; Yildiz A
Emerg Med J; 2006 Jul; 23(7):537-9. PubMed ID: 16794097
[TBL] [Abstract][Full Text] [Related]
6. [First experience with the cobalt binding capacity (ACB) test in the diagnosis of acute coronary syndrome (a pilot study)].
Stejskal D; Lacnák B; Juráková R; Adamovská S; Prosková J; Ochmanová R; Ozanová G
Vnitr Lek; 2004 Oct; 50(10):734-9. PubMed ID: 15633927
[TBL] [Abstract][Full Text] [Related]
7. Effect of albumin concentration and serum matrix on ischemia-modified albumin.
Hakligör A; Kösem A; Seneş M; Yücel D
Clin Biochem; 2010 Feb; 43(3):345-8. PubMed ID: 19769954
[TBL] [Abstract][Full Text] [Related]
8. [Ischemia-modified albumin: new marker of myocardial ischemia?].
Dusek J; Tichý M; Stásek J; Bis J; Gregor J; Pudil R; Vojácek J
Cas Lek Cesk; 2005; 144(5):295-7; discussion 297. PubMed ID: 16013513
[TBL] [Abstract][Full Text] [Related]
9. Interference-free determination of ischemia-modified albumin using quantum dot coupled X-ray fluorescence spectroscopy.
Luo Y; Wang C; Jiang T; Zhang B; Huang J; Liao P; Fu W
Biosens Bioelectron; 2014 Jan; 51():136-42. PubMed ID: 23948244
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.
Coverdale JPC; Katundu KGH; Sobczak AIS; Arya S; Blindauer CA; Stewart AJ
Prostaglandins Leukot Essent Fatty Acids; 2018 Aug; 135():147-157. PubMed ID: 30103926
[TBL] [Abstract][Full Text] [Related]
11. Albumin cobalt binding assay to rule out acute coronary syndrome.
Abadie JM; Blassingame CL; Bankson DD
Ann Clin Lab Sci; 2005; 35(1):66-72. PubMed ID: 15830711
[TBL] [Abstract][Full Text] [Related]
12. Biological variation of ischaemia-modified albumin in healthy subjects.
Govender R; De Greef J; Delport R; Becker PJ; Vermaak WJ
Cardiovasc J Afr; 2008; 19(3):141-4. PubMed ID: 18568173
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.
Christenson RH; Duh SH; Sanhai WR; Wu AH; Holtman V; Painter P; Branham E; Apple FS; Murakami M; Morris DL
Clin Chem; 2001 Mar; 47(3):464-70. PubMed ID: 11238298
[TBL] [Abstract][Full Text] [Related]
14. Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia.
Lu J; Stewart AJ; Sadler PJ; Pinheiro TJ; Blindauer CA
J Med Chem; 2012 May; 55(9):4425-30. PubMed ID: 22519414
[TBL] [Abstract][Full Text] [Related]
15. Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay.
Oh BJ; Seo MH; Kim HS
Biomarkers; 2012 Aug; 17(5):394-401. PubMed ID: 22630368
[TBL] [Abstract][Full Text] [Related]
16. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation.
Roy D; Quiles J; Sinha M; Aldama G; Gaze D; Kaski JC
Am J Cardiol; 2004 Feb; 93(3):366-8. PubMed ID: 14759394
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: implication on the albumin cobalt binding test for detecting myocardial ischemia.
Mothes E; Faller P
Biochemistry; 2007 Feb; 46(8):2267-74. PubMed ID: 17274600
[TBL] [Abstract][Full Text] [Related]
18. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention.
Sinha MK; Gaze DC; Tippins JR; Collinson PO; Kaski JC
Circulation; 2003 May; 107(19):2403-5. PubMed ID: 12742986
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of a nickel-albumin binding assay for assessment of myocardial ischaemia.
da Silva SH; Hausen Bdos S; da Silva DB; Becker AM; de Campos MM; Duarte MM; Moresco RN
Biomarkers; 2010 Jun; 15(4):353-7. PubMed ID: 20384453
[TBL] [Abstract][Full Text] [Related]
20. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.
Chen CY; Tsai WL; Lin PJ; Shiesh SC
Clin Chem Lab Med; 2011 Nov; 49(11):1817-21. PubMed ID: 21851314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
